We are live on ! Find out more
TS

Thomas Steyer Farallon Capital Management

AUM $21.7B
1-Year Est. Return 79.24%
 

Thomas Steyer founded Farallon Capital Management, a pioneering multi-strategy firm spanning credit, equities, real estate, and event-driven investing. Farallon became known for rigorous research and opportunistic capital allocation across cycles. Although Steyer later focused on public advocacy, the Farallon name remains important in hedge fund history and ongoing 13F tracking.

This Fund
S&P 500
This Quarter Est. Return
+2.09%
1 Year Est. Return
+79.24%
3 Year Est. Return
+204.51%
5 Year Est. Return
+270.91%
10 Year Est. Return
+1,884.18%
AUM
$6.23B
AUM Growth
-$694M
Cap. Flow
-$755M
Cap. Flow %
-12.12%
Top 10 Hldgs %
36.61%
Holding
115
New
19
Increased
25
Reduced
18
Closed
31

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 19.07%
2 Healthcare 13.74%
3 Communication Services 12.07%
4 Technology 10.64%
5 Consumer Staples 9.36%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
EGRX
76
DELISTED
Eagle Pharmaceuticals, Inc.
EGRX
$1.26M 0.02%
100,000
STML
77
DELISTED
Stemline Therapeutics, Inc.
STML
$1.18M 0.02%
95,000
LRMR icon
78
Larimar Therapeutics
LRMR
$434M
$1.18M 0.02%
+5,000
New +$1.13M
FATE icon
79
Fate Therapeutics
FATE
$279M
$880K 0.01%
171,196
-76,906
-31% -$445K
QURE icon
80
uniQure
QURE
$3.36B
$463K 0.01%
50,000
ACAD icon
81
Acadia Pharmaceuticals
ACAD
$5.08B
-70,000
Closed -$1.58M
AMAT icon
82
Applied Materials
AMAT
$391B
-639,225
Closed -$14.1M
CPA icon
83
Copa Holdings
CPA
$5.88B
-474,970
Closed -$67.7M
GRFS
84
Grifois
GRFS
$5.44B
-102,764
Closed -$2.26M
IBP icon
85
Installed Building Products
IBP
$6.56B
-48,398
Closed -$593K
NGNE icon
86
Neurogene
NGNE
$773M
-2,405
Closed -$451K
ORCL icon
87
Oracle
ORCL
$422B
-2,720,000
Closed -$110M
PFE icon
88
Pfizer
PFE
$160B
-1,059,270
Closed -$29.8M
VNET
89
VNET Group
VNET
$1.91B
-1,460,000
Closed -$43.8M
WY icon
90
Weyerhaeuser
WY
$17.6B
-2,425,000
Closed -$80.2M
WY icon
91
PUT
Weyerhaeuser
WY
$17.6B
-1,768,000
Closed -$58.5M
TXNM
92
TXNM Energy Inc
TXNM
$5.9B
-365,000
Closed -$10.7M
VIRX
93
DELISTED
Viracta Therapeutics, Inc. Common Stock
VIRX
-3,190
Closed -$4.37M
MNK
94
CALL
DELISTED
MALLINCKRODT PUBLIC LIMITED COMPANY
MNK
-348,600
Closed -$27.9M
ARQL
95
DELISTED
Arqule Inc
ARQL
-1,258,732
Closed -$1.95M
ALDR
96
DELISTED
Alder Biopharmaceuticals
ALDR
-100,000
Closed -$2.01M
FRED
97
DELISTED
Fred's Inc
FRED
-283,324
Closed -$4.33M
CORI
98
DELISTED
Corium International, Inc.
CORI
-125,000
Closed -$971K
PF
99
DELISTED
Pinnacle Foods, Inc.
PF
-790,000
Closed -$26M
OCIP
100
DELISTED
OCI Partners LP
OCIP
-198,592
Closed -$4.22M

Similar funds

Thomas Steyer's Q3 2014 Portfolio in Review

As of Q3 2014, Thomas Steyer held 115 positions worth $6.23B, down 10% from $6.93B the previous quarter. Its ten largest holdings account for 37% of the portfolio.

Thomas Steyer withdrew a net $755M in Q3 2014, closing 31 positions and reducing 18 holdings. Its most notable exit was FOREST LABORATORIES INC, an estimated $792M position sold in full.

By sector, the portfolio is most concentrated in Consumer Discretionary at 19% of assets, up from 12% a quarter earlier, followed by Healthcare and Communication Services.

Against the trend, Thomas Steyer opened a new position in Time Warner Inc worth $178M.

  • Thomas Steyer's largest Q3 2014 buy was Time Warner Inc: 2,365,000 shares worth $178M.
  • Thomas Steyer added most to DIRECTV COM STK (DE) in Q3 2014, an estimated $233M increase.
  • Thomas Steyer's biggest Q3 2014 reduction was American Tower, cutting an estimated $99M.
  • Thomas Steyer fully exited FOREST LABORATORIES INC in Q3 2014, selling an estimated $792M.
  • Thomas Steyer's ten largest holdings make up 37% of its $6.23B portfolio in Q3 2014.
  • Thomas Steyer opened 19 new positions and closed 31 in Q3 2014.
  • Thomas Steyer's portfolio value fell 10% quarter-over-quarter to $6.23B.

Based on Farallon Capital Management's 13F filing for Q3 2014, filed 14 Nov 2014.